Time Limit Dooms Nexium Antitrust Claims, AstraZeneca Says

Time Limit Dooms Nexium Antitrust Claims, AstraZeneca Says

AstraZeneca PLC and Ranbaxy Inc. filed for partial summary judgment Tuesday in multidistrict litigation alleging the companies violated antitrust laws by agreeing to delay entry of a generic version of AstraZeneca’s heartburn drug Nexium, saying ...read more

  • Tags: